ANTERIS TECHNOLOGIES GLOBAL
AVRNASDAQTrading Snapshot
- Day Range
- $241.19 β $246.39
- 52-Week Range
- $3.30 β $11.06
- Volume
- $3.12B
- Avg Volume
- $2.65B
- Shares Outstanding
- 97.3M
- Next Earnings
- Oct 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $2M
- Last Q Revenue
- $1M
- P/E Ratio
- β
- P/S Ratio
- 334.3x
- EPS (TTM)
- $-1.93
- Dividend Yield
- β
- Dilution (1yr)
- +0.0%
Why Investors Own AVR
- βHigh-growth profile β revenue up +11.1% YoY with expanding US Equity exposure.
- βHealthy economics β 77% gross margin and 12% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ANTERIS TECHNOLOGIES GLOBAL
AVRAbout ANTERIS TECHNOLOGIES GLOBAL
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
ANTERIS TECHNOLOGIES GLOBAL tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift AVR price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ANTERIS TECHNOLOGIES GLOBAL announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.